Clinical Start-up PERT Estimate

Clinical study start-up three-point PERT

This three-point PERT chart estimates clinical study start-up while exposing uncertainty in regulatory review and site activation. A draft protocol begins ethics review and site selection. Selected sites are contracted, then training waits for both the ethics decision and signed site contracts. Enrollment opens only after training. Optimistic, likely and pessimistic durations give the team a way to plan around review timing and contract variability without treating them as fixed. Extend the network with budget approval, investigator meetings, data-system validation or drug supply release when those steps affect study activation.

Type PERT / GanttNorme PMI PMBOK 7 + Moder 1983 (AON/PDM)Moteur schematex-pertMis à jour 24/09/2026

La demande

“Create a three-point PERT estimate for clinical study start-up: draft protocol, complete ethics review, select sites, contract sites, train sites, then open enrollment.”

Essayez ensuiteAdd a data-system validation before enrollment.Change the likely ethics review duration to fourteen days.

Ce que contient ce dessin

Comprenez les décisions qui le sous-tendent.

01Protocol gate

Ethics and site selection begin after the draft.

02Site gate

Contracting follows selection.

03Activation gate

Training needs ethics approval and contracts.

Use for an early clinical study plan.

Voir tous les modèles de PERT / Gantt →

FAQ

Questions fréquentes

Why use three-point estimates?

Review and contracting durations are uncertain.

What blocks training?

Ethics review and site contracts.

When does enrollment open?

After site training.